MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- CORAL LAB.
CORAL LAB. Share Price (CRLB)
Here is the latest stock price and chart of CORAL LAB.. For more details, see the CORAL LAB. company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Watch Now: A Massive 15x Opportunity in Electric Vehicles
| Live BSE Quotes | Oct 26, 2021 11:38:00 AM | ||
|---|---|---|---|
| Price (Rs)378.00 | Open (Rs) 375.00 | High (Rs) 382.00 | Low (Rs) 373.00 |
| % Change2.59 | Volume 270 | Value (Rs) 102,060 | 52-Week H/L 582.30 / 265.80 |
| Live NSE Quotes |
|---|
| Not listed |
| Change | |||||
|---|---|---|---|---|---|
| 1 Day 2.59% | 1 Month -3.58% | 3 Months -11.07% | 1 Year 1.85% | 5 Years (CAGR)* -9.32% | 10 Years (CAGR)* 17.23% |
* Compound Annual Growth Rate
| Valuation | ||||
|---|---|---|---|---|
| EPS (Rs)* 39.44 | P/E Ratio (x) 9.58 | Market Cap (Rs m) 1,350.44 | P/BV (x) 1.17 | Dividend Yield (%) 0.00 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
CORAL LAB. Share Price Today:
CORAL LAB. share price is up 2.6% to Rs 378.0 on the BSE. The total volume of shares traded is 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index is trading up by 0.1%. And the benchmark S&P BSE SENSEX is at 60,876.2 (down 0.1%).
Over the last 30 days, the CORAL LAB. share price is down 6.0%. And over the last one year, CORAL LAB. share price is down 0.7%.
The current market capitalisation of CORAL LAB. stands at Rs 1,350.44 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of September 2021, company promoters held 71.51% stake in CORAL LAB., with no shares having been pledged. To know more, check out the latest shareholding pattern of CORAL LAB..
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- Top Gainers Today BSE A Group
- Top Gainers Today NSE Above Rs 20
- Top Gainers Today BSE Above Rs 20
- Top Gainers Today BSE Sensex
- Top Gainers Today BSE Small Cap
- Top Gainers Today BSE 500
- Top Losers Today BSE A Group
- Most Active Stocks Rs 1 to 2
- Top Losers Today NSE Above Rs 20
- Buzzing Stocks Today
- Most Popular Stocks BSE 30
- TRENDING ON EQUITYMASTER:
- Warren Buffett - The Value Investor
- Your Ultimate Guide to Penny Stock Investing
- How to Invest in Gold
- Basics of Value Investing
- Benjamin Graham
- The Best Bluechip Stocks to Buy
- How to Invest in Silver
- The Best Small-cap Stocks to Buy
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Best Stocks to Buy Today
- How to Use P/E for Successful Investing
- How to Find Undervalued Stocks
- Differences Between Trading and Investing
- SWOT Analysis for Stocks
- The Best Dividend Stocks to Buy
Today's Market
Sensex Up 400 Points, Nifty Above 18,250; Tech Mahindra & Tata Motors Surge 5%(10:30 am)
Asian share markets are trading higher today, boosted by gains in US shares that hit record highs as Tesla topped US$1 tn in value.
Related Views On News
Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)
Oct 8, 2021The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.
Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)
Sep 30, 2021The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.
5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)
Sep 3, 2021These companies are likely to benefit the most from Covid-19 vaccines.
Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)
Aug 16, 2021The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.
J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)
Aug 13, 2021The company seeks to expand the market for prescription lozenges with new launches this year.
More Views on NewsMost Popular
5 Green Energy Stocks to Watch as India Readies for a Revolution (Views On News)
Oct 13, 2021The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.
Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You... (Profit Hunter)
Oct 13, 2021Why should investors take it for granted that India's Tesla will be one of the major auto stocks?
Tata Group Stocks are on Fire: Which one Should You Buy? (Profit Hunter)
Oct 15, 2021Tata group stocks are on fire. Find out which one deserves your attention.
Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally (Views On News)
Oct 13, 2021Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.
India's Big PSU Selloff: Watch Out for these Top Stocks (Views On News)
Oct 15, 2021The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2022
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: How to Profit from Sensex 100,000
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
TRACK CORAL LAB.
- Track your investment in CORAL LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON CORAL LAB.
CORAL LAB. 5-YR ANALYSIS
COMPARE CORAL LAB. WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
FOLLOW
APP
EQUITYMASTER SUPPORTS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.